Showing results (1231-1240 of 1,376) with videos related to

Sort By:
Pageof 138
Issues in Mental Health Nursing|September 20, 2021
Adaptation of the TEAM Mental Healthcare Delivery Model: A Mixed-Methods EvaluationGabriela A Nagy PhD, Macey L Arnold Bs, Jane P Gagliardi Md, et al.
Molecular Genetics and Metabolism|November 16, 2004
Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the testR Saunders-Pullman, N Blau, K Hyland, et al.
Lancet (London, England)|March 10, 2018
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen A Harrison, Mary E Rinella, Manal F Abdelmalek, et al.
Nature Communications|February 3, 2021
Genomic evidence of prevalent hybridization throughout the evolutionary history of the fig-wasp pollination mutualismGang Wang, Xingtan Zhang, Edward Allen Herre, et al.
Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.
Ear and Hearing|March 27, 2026
Familism, Family Cohesion, and Hearing Loss in U.S. Hispanic/Latino AdultsLaura Coco, Ariana M Stickel, Pablo Martinez-Amezcua, et al.
Multiple Sclerosis and Related Disorders|April 23, 2021
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development programKrzysztof W Selmaj, Jeffrey A Cohen, Giancarlo Comi, et al.
JAMA Neurology|August 28, 2020
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical TrialBruce A C Cree, Myla D Goldman, John R Corboy, et al.
Physical Review Letters|December 9, 2017
Unexpected Sensitivity of Nitrogen Ions Superradiant Emission on Pump Laser Wavelength and DurationYi Liu, Pengji Ding, Neven Ibrakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populationsEline Me Coerver, Sezgi Kaçar, Olga Ciccarelli, et al.
Pageof 138